|
|
|
|
|
| October 21,
2010 | ISSUE NUMBER 171 VOL 8 |
Layoffs
A Year of Big Layoffs for Big Pharma
What are the factors driving the layoffs that have taken place at virtually all the Big Pharma companies this year?
Neglected Diseases
WHO Brings Big Pharma Together to Fight Neglected Diseases
A new report from WHO on overcoming the impact of neglected tropical diseases has spawned a $150 million funding and donation initiative from Big Pharma.
Commentary
Industry, Patents, and Public Health: Wimps on the Barbie?
The welcome news of a compact between industry and the WHO to fight neglected diseases in the developing world only highlights a much more spotty industry record of engagement on sensitive policy issues such as intellectual property rights, says William Looney.
M&A
Pfizer To Acquire King Pharmaceuticals
The merger, announced last week, will cost the drug maker $3.6 billion.
|
|
 // Tengion (East Norriton, Pa.) announced it has appointed Richard E. Kuntz, MD, M.Sc., Senior Vice President and Chief Scientific, Clinical, and Regulatory Officer of Medtronic, to its Board of Directors. //AstraZeneca's Regional VP of Northern Europe, Martin Wright, was named Regional VP for Japan.//Catabasis Pharmaceuticals (Cambridge, Mass.) announced the appointment of Michael Curtis, Ph.D., to Vice President, product development. //Dr. Christel Fenge joined the Sartorius Stedim Biotech group (Aubagne, France) as Vice President of Marketing for Fermentation Technologies. // |
|
|
|
|
|
Nov 4: SharePoint User Workshop for the Life Sciences Industry
Princeton, NJ
Nov 16–18: Risk-Based Decision Making
Burlingame, CA
Dec 5–7: Clinic 2010 Symposium: Achieving the Vision — Advancing High-Value Health Care
Bethesda, MD
Dec 8–9: CMAC 2010 – Commercialization and Market Access Congress
Orlando, FL |
|
 |
|
|
|
PE House
Watch the new pharma interview show: PHARMA FACEOFF
Expert insights delivered to your desktop or mobile device.
Features the best in biopharma debating today’s most pressing issues.
Rate the episode, share or like us on Facebook, post it on your site.
Hosted by Barbara Ryan, pharmaceutical analyst from Deutsche Bank.
A presentation of Pharmaceutical Executive.
 WATCH ONE MINUTE PREVIEW
|
Take the Safe Path to creating ERP Value.
You simply cannot afford to handle the complexities of chargebacks, scalability, and compliance with ERP “solutions” that don’t add value to your bottom line. Moving forward with a new solution? Learn how to avoid the pitfalls, and manage risk, during all stages of an ERP project, so that you can enjoy the payoffs quickly and (relatively) painlessly.
.
 Read more...
|
 |
|
|
|
|
 |
|
 |
|
 |
| What is likely to be the most promising therapy area of the next 10 years? |
|
|
| |
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
